Literature DB >> 1556891

Vocal evaluation of thyroplastic surgery in the treatment of unilateral vocal fold paralysis.

S D Gray1, J Barkmeier, D Jones, I Titze, D Druker.   

Abstract

Vocal function was assessed in 15 patients who received thyroplasty type I for the rehabilitation of unilateral vocal fold paralysis. The function was assessed by perceptual evaluation, voice intensity and frequency range profiles, and questionnaire. Goals of the study were to evaluate the efficacy of thyroplasty in improving the voice, to compare postoperative thyroplasty voices to normal voices, and to correlate objective measurements to the results of the questionnaire regarding satisfaction with the voice. Perceptual evaluations were performed by randomizing normal and thyroplasty voices on a recording tape. The voices on the tape were then rated by independent, blinded, trained listeners. The perceptual qualities of pitch, intonation, and loudness were not statistically different than normals; however, voice qualities of strain, breathiness, hoarseness, harshness, and unsteadiness were different than normals. Mean frequency range and mean intensity range were moderately to severely reduced from normals with a wide variation being present in the results. The correlation between the higher threshold phonation pressures and decreased intensity ranges found in some patients is discussed. Questionnaire results indicated that a high degree of satisfaction with the surgery was present (92%). Extreme or general satisfaction with voice was present in 73%. The most difficult voicing was experienced at work, with 25% needing to adjust their employment to accommodate their voice abilities. These results indicate that thyroplasty type I is effective in partially rehabilitating unilateral voice fold paralysis. Voice function is still not normal, probably in part due to the underlying disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1556891     DOI: 10.1288/00005537-199204000-00008

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

1.  Life Experience of Patients With Unilateral Vocal Fold Paralysis.

Authors:  David O Francis; Ariel E Sherman; Kristen L Hovis; Kemberlee Bonnet; David Schlundt; C Gaelyn Garrett; Louise Davies
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-05-01       Impact factor: 6.223

2.  Medialization laryngoplasty-A study of 15 cases.

Authors:  Annop Raj; Manish Girhotra; Ravi Meher
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2004-10

3.  [Treatment of glottal gap].

Authors:  S Voigt-Zimmermann; C Arens
Journal:  HNO       Date:  2013-02       Impact factor: 1.284

Review 4.  Aerodynamic measures of glottal function: what extra can they tell us and how do they guide management?

Authors:  Jack J Jiang; Allison L Maytag
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2014-12       Impact factor: 2.064

Review 5.  Voice outcome indicators for unilateral vocal fold paralysis surgery: a review of the literature.

Authors:  G Desuter; M Dedry; B Schaar; J van Lith-Bijl; P P van Benthem; E V Sjögren
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-20       Impact factor: 2.503

6.  Multidimensional assessment of functional outcomes of medialization thyroplasty.

Authors:  Virgilijus Uloza; Ruta Pribuisiene; Viktoras Saferis
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-12-10       Impact factor: 2.503

7.  Phonosurgery--outcomes of varied techniques.

Authors:  G S Berke
Journal:  West J Med       Date:  1995-08

8.  Pre and post operative voice analysis after medialization thyroplasty in cases of unilateral vocal fold paralysis.

Authors:  Kanishka Chowdhury; Somnath Saha; Vedula Padmini Saha; Sudipta Pal; Indranil Chatterjee
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-03-23

9.  Framework Surgery for Treatment of Unilateral Vocal Fold Paralysis.

Authors:  James J Daniero; C Gaelyn Garrett; David O Francis
Journal:  Curr Otorhinolaryngol Rep       Date:  2014-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.